Oligogenic variants in NEK1 and ATXN2 in amyotrophic lateral sclerosis: report of two cases and review of the literature.

Amyotroph Lateral Scler Frontotemporal DegenerJun 10, 2026 (epub)

Émy Roy, Mathieu Blais, Patrick Dion et al.

✦ AI-curated · Sources linked

Case in brief

Two siblings with amyotrophic lateral sclerosis (ALS) were found to carry both a heterozygous ATXN2 32 CAG repeat expansion and a novel heterozygous NEK1 c.1674_1677dup variant. In a large family with thirteen siblings, segregation of both variants was reported. The authors considered this pattern supportive of a possible oligogenic contribution to ALS susceptibility, while noting that the variants’ pathogenic roles remain uncertain.

What made this case unusual

Both affected siblings carried variants in two ALS-associated genes, raising the possibility of an oligogenic rather than single-variant contribution.

Diagnostic / clinical pearl

When interpreting ALS genetic findings, consider that variants of uncertain pathogenicity may occur together; family segregation can inform, but does not establish, their contribution to disease.

Source

Published in Amyotroph Lateral Scler Frontotemporal Degener. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.